MEDICATION-INDUCED TAKOTSUBO SYNDROME: INSIGHTS FROM FDA ADVERSE EVENT REPORTING SYSTEM DATABASE

被引：0
|
作者：
Niu, Haiming
Yuan, Yong, Sr.
Li, Jianwei, Sr.
Shi, Ao
Cai, Peng
Chen, Miaolian
Peddibhotla, Bharath
Liang, Hongkai
Feng, Li, Sr.
Li, Mingxing, Sr.
Teng, Catherine
Li, Pengyang
机构：
[1] Virginia Commonwealth Univ, Richmond, VA USA
[2] Zhongshan Peoples Hosp, Zhongshan, Peoples R China
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：740 / 740
页数：1
相关论文
共 50 条
  • [21] Venetoclax and Tumor Lysis Syndrome (TLS): Data Mining of the FDA Adverse Event Reporting System (FAERS) Database
    Giorgio, C. D.
    Pascale, G.
    Cimarusti, C. C.
    Corru, F.
    Drago, D.
    Napoli, L.
    Ingrilli, S.
    Ruggiero, F.
    Cervi, L.
    [J]. DRUG SAFETY, 2022, 45 (10) : 1155 - 1156
  • [22] Adverse event profile differences between rituximab and ocrelizumab: findings from the fda adverse event reporting database
    Caldito, N. Gonzalez
    Shirani, A.
    Salter, A.
    Stuve, O.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 257 - 257
  • [23] Adverse event profile differences between rituximab and ocrelizumab: Findings from the FDA Adverse Event Reporting Database
    Caldito, Natalia Gonzalez
    Shirani, Afsaneh
    Salter, Amber
    Stuve, Olaf
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (07) : 1066 - 1076
  • [24] Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database
    Poluzzi, Elisabetta
    Raschi, Emanuel
    Koci, Ariola
    Moretti, Ugo
    Spina, Edoardo
    Behr, Elijah R.
    Sturkenboom, Miriam
    De Ponti, Fabrizio
    [J]. DRUG SAFETY, 2013, 36 (06) : 467 - 479
  • [25] Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database
    Elisabetta Poluzzi
    Emanuel Raschi
    Ariola Koci
    Ugo Moretti
    Edoardo Spina
    Elijah R. Behr
    Miriam Sturkenboom
    Fabrizio De Ponti
    [J]. Drug Safety, 2013, 36 : 467 - 479
  • [26] Pharmacovigilance of esketamine nasal spray: an analysis of the FDA adverse event reporting system database
    Liu, Ruixue
    Liu, Chunxiao
    Feng, Dianwei
    Guo, Tongxin
    Wang, Ying
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [27] Botulinum Toxin Type A Overdoses: Analysis of the FDA Adverse Event Reporting System Database
    Rashid Kazerooni
    Edward P. Armstrong
    [J]. Clinical Drug Investigation, 2018, 38 : 867 - 872
  • [28] Botulinum Toxin Type A Overdoses: Analysis of the FDA Adverse Event Reporting System Database
    Kazerooni, Rashid
    Armstrong, Edward P.
    [J]. CLINICAL DRUG INVESTIGATION, 2018, 38 (09) : 867 - 872
  • [29] Botulinum toxin type A overdoses: analysis of the FDA adverse event reporting system database
    Kazerooni, Rashid
    [J]. NEUROLOGY, 2019, 92 (15)
  • [30] Evaluation of antibiotic-induced taste and smell disorders using the FDA adverse event reporting system database
    Kan, Yusuke
    Nagai, Junko
    Uesawa, Yoshihiro
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
12345